Nitiz Murdia: In IVF, Small Process Gaps in the Lab Quietly Compound into Lost Outcomes
Nitiz Murdia, Director of the Embryology Lab at Indira IVF Group, shared on LinkedIn about a paper he co-authored with colleagues, published in Reproductive BioMedicine Online:
”In IVF, small process gaps in the lab quietly compound into lost outcomes and lost revenue.
A new study shows that simply auditing lab compliance systematically lifted blastocyst rates by over 5 points and biochemical pregnancy rates by 3+ points, alongside a significant jump in protocol compliance (74.4% – 80.1%).
The study analysed 34,461 ICSI cycles across 30 centres and demonstrated how our structured audits, 149 quality checkpoints, standardised protocols and digital monitoring were associated with measurable improvements in laboratory compliance, blastocyst formation and biochemical pregnancy rates.
For multi-clinic networks, this is a low-cost, high-leverage lever: standardized auditing as a scalable path to better outcomes and stronger unit economics across centres.”
Title: Systematic standardization improves compliance and performance across a large IVF network through audits and digitally enabled quality management
Authors: Naval Shah, Vivek Dave, Vipin Chandra, Navneet Singh, Babasaheb Ghodke, Nitiz Murdia, Alison Campbell, Piyush Kakadiya, Jishnu PS, Satardu De, Ritesh Aggarwal, Divreena Talwar, Walmik Mistari, Anurag Chittora, Kshitiz Murdia.
You can read the Full Article in Reproductive BioMedicine Online.

Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic
